Albert Seymour
2019
In 2019, Albert Seymour earned a total compensation of $1.9M as Chief Scientific Officer at Homology Medicines, a 12% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $162,240 |
|---|---|
| Option Awards | $1,295,756 |
| Salary | $405,600 |
| Other | $13,231 |
| Total | $1,876,827 |
Seymour received $1.3M in option awards, accounting for 69% of the total pay in 2019.
Seymour also received $162.2K in non-equity incentive plan, $405.6K in salary and $13.2K in other compensation.
Rankings
In 2019, Albert Seymour's compensation ranked 6,249th out of 13,971 executives tracked by ExecPay. In other words, Seymour earned more than 55.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,249 out of 13,971 | 55th |
Division Manufacturing | 2,349 out of 5,701 | 59th |
Major group Chemicals And Allied Products | 857 out of 2,200 | 61st |
Industry group Drugs | 724 out of 1,886 | 62nd |
Industry Pharmaceutical Preparations | 537 out of 1,398 | 62nd |
Source: SEC filing on April 28, 2020.
Seymour's colleagues
We found two more compensation records of executives who worked with Albert Seymour at Homology Medicines in 2019.